-
Nu.Q® Technology
Our technology detects characteristic epigenetic changes in nucleosomes that occur from the earliest stages of cancer, sepsis and other diseases.
-
- Our Tests
- Human Health
-
Nu.Q® NETs
Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.
-
Nu.Q® Discover
Buy our Nu.Q® Discover H3.1 Research Use Only Assay
- Animal Health
-
Nu.Q® Vet Cancer Test
Nu.Q® Vet Cancer Test detects 76% of systemic cancers at 97% specificity.
Scaling Up for Success: Volition Partners with IVD Research for US Manufacturing
- Share
- Tweet
- Share on Facebook
- Share
As part of our US clinical operations in Carlsbad, we’ve outsourced the manufacture of Volition’s products for the US market to IVD Research, an established contract development and manufacturing organization.
IVD Research is an FDA-registered manufacturer, ISO 13485 certified, and undertakes all aspects of contract manufacturing for us – from assembling the key components to shipping kits to our customers. IVD Research is well equipped to scale with Volition, actively adding to their capacity at the moment, to meet future increasing demand.
We heard from Volition Chief Operating Officer, Gaetan Michel, IVD Research Chief Operating Officer, Chris Lambillotte, and IVD Research President, Dave Lambillotte:
I think it’s the biggest no-brainer in my history to say that they [Volition] are going to do fabulous. I have never seen a product as innovative, as cost-effective and as effective as what they are doing.
Dave Lambillotte
President of IVD Research
Subscribe for Volition product updates.
Or, click here for Investor Updates and press releases.
"*" indicates required fields